These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19498007)

  • 1. Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.
    Gjerstorff M; Burns JS; Nielsen O; Kassem M; Ditzel H
    Am J Pathol; 2009 Jul; 175(1):314-23. PubMed ID: 19498007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing's sarcoma?
    Burns JS; Abdallah BM; Schrøder HD; Kassem M
    Histol Histopathol; 2008 Oct; 23(10):1229-40. PubMed ID: 18712675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.
    Burns JS; Abdallah BM; Guldberg P; Rygaard J; Schrøder HD; Kassem M
    Cancer Res; 2005 Apr; 65(8):3126-35. PubMed ID: 15833842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult human mesenchymal stem cell as a target for neoplastic transformation.
    Serakinci N; Guldberg P; Burns JS; Abdallah B; Schrødder H; Jensen T; Kassem M
    Oncogene; 2004 Jun; 23(29):5095-8. PubMed ID: 15107831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells.
    Teng IW; Hou PC; Lee KD; Chu PY; Yeh KT; Jin VX; Tseng MJ; Tsai SJ; Chang YS; Wu CS; Sun HS; Tsai KD; Jeng LB; Nephew KP; Huang TH; Hsiao SH; Leu YW
    Cancer Res; 2011 Jul; 71(13):4653-63. PubMed ID: 21518779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decellularized matrix from tumorigenic human mesenchymal stem cells promotes neovascularization with galectin-1 dependent endothelial interaction.
    Burns JS; Kristiansen M; Kristensen LP; Larsen KH; Nielsen MO; Christiansen H; Nehlin J; Andersen JS; Kassem M
    PLoS One; 2011; 6(7):e21888. PubMed ID: 21779348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
    James SR; Link PA; Karpf AR
    Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.
    Røsland GV; Svendsen A; Torsvik A; Sobala E; McCormack E; Immervoll H; Mysliwietz J; Tonn JC; Goldbrunner R; Lønning PE; Bjerkvig R; Schichor C
    Cancer Res; 2009 Jul; 69(13):5331-9. PubMed ID: 19509230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.
    Abdallah BM; Haack-Sørensen M; Burns JS; Elsnab B; Jakob F; Hokland P; Kassem M
    Biochem Biophys Res Commun; 2005 Jan; 326(3):527-38. PubMed ID: 15596132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas.
    Siddiqi S; Mills J; Matushansky I
    Curr Stem Cell Res Ther; 2010 Mar; 5(1):63-73. PubMed ID: 19807660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues.
    Xu X; Zhang X; Wang S; Qian H; Zhu W; Cao H; Wang M; Chen Y; Xu W
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):495-504. PubMed ID: 20473524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer.
    Vanderstraeten A; Tuyaerts S; Everaert T; Van Bree R; Verbist G; Luyten C; Amant F
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
    Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
    Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
    Jacobs JF; Brasseur F; Hulsbergen-van de Kaa CA; van de Rakt MW; Figdor CG; Adema GJ; Hoogerbrugge PM; Coulie PG; de Vries IJ
    Int J Cancer; 2007 Jan; 120(1):67-74. PubMed ID: 17019710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
    Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
    Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of cancer testis antigen genes in glioma stem cells.
    Yawata T; Nakai E; Park KC; Chihara T; Kumazawa A; Toyonaga S; Masahira T; Nakabayashi H; Kaji T; Shimizu K
    Mol Carcinog; 2010 Jun; 49(6):532-44. PubMed ID: 20082319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.